Finance

Lists
PTX:ASX
Prescient Therapeutics Ltd
0,066 A$
0,00%
(0,00) 1D
9 հոկ, 16:10:30 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PTX...
Open
0,07 A$
High
0,07 A$
Low
0,06 A$
Mkt. cap
71,18 մլն
Avg. vol.
1,04 մլն
Volume
736,35 հզր
52-wk high
0,12 A$
52-wk low
0,04 A$
EPS
-0,01 A$
Shares outstanding
1,14 մլրդ
No. of employees
3
Open
0,07 A$
High
0,07 A$
Low
0,06 A$
Mkt. cap
71,18 մլն
Avg. vol.
1,04 մլն
Volume
736,35 հզր
52-wk high
0,12 A$
52-wk low
0,04 A$
EPS
-0,01 A$
Shares outstanding
1,14 մլրդ
No. of employees
3
News stories
From web sources and news partners
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
Founded22 մյս, 1986 թ.
Headquarters-
Sector-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
578,89 հզր
578,89 հզր
1,15 մլն
1,15 մլն
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,24 մլն
1,24 մլն
1,40 մլն
1,40 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,13 մլն
1,13 մլն
1,20 մլն
1,20 մլն
Operating expense
2,57 մլն
2,57 մլն
2,73 մլն
2,73 մլն
Total operating expenses
2,57 մլն
2,57 մլն
2,73 մլն
2,73 մլն
Operating income
-1,99 մլն
-1,99 մլն
-1,58 մլն
-1,58 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-1,99 մլն
-1,99 մլն
-1,51 մլն
-1,51 մլն
EBT excluding unusual items
-1,99 մլն
-1,99 մլն
-1,51 մլն
-1,51 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,99 մլն
-1,99 մլն
-1,51 մլն
-1,51 մլն
Net profit margin
-344,35%
-344,35%
-131,51%
-131,51%
Earnings per share
-
-
-
-
Interest and investment income
1,86 հզր
1,86 հզր
67,39 հզր
67,39 հզր
Interest expense
-2,97 հզր
-2,97 հզր
-2,38 հզր
-2,38 հզր
Net interest expenses
-1,12 հզր
-1,12 հզր
65,02 հզր
65,02 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-1,55 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps